AnaMar is a privately held, clinical-stage biotech company developing a first-in-class, orally bioavailable, peripheral-acting 5-HT 2B receptor antagonist, AM1476, as a pan anti-fibrotic medicine... We are combining our innovative therapeutic..
Relevance: 103.51672